Evidence map›Paper›PMID 32632734›Full record

ArticleCell stress & chaperones2020

Inhibition of USP14 induces ER stress-mediated autophagy without apoptosis in lung cancer cell line A549.

Ali-Asghar Moghadami, Elmira Aboutalebi Vand Beilankouhi, Ashkan Kalantary-Charvadeh, Masoud Hamzavi, Bashir Mosayyebi, Hassan Sedghi, Amir Ghorbani Haghjo, Saeed Nazari Soltan Ahmad

Open access · greenAbstract read
In one paragraph

Article in Cell stress & chaperones, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. The cross-talk between NRF2 and apoptosis in cancer.Medical molecular morphology · 2025
    Review
  3. Role of the USP family in autophagy regulation and cancer progression.Apoptosis : an international journal on programmed cell death · 2025
    Review
  4. Role of the USP family in autophagy regulation and cancer progression.Apoptosis : an international journal on programmed cell death · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Deubiquitylating Enzymes in Cancer and Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  11. Targeting the deubiquitinaseOncology reports · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases.International journal of molecular sciences · 2021
    Review
  18. Deubiquitinases: Modulators of Different Types of Regulated Cell Death.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ali-Asghar Moghadami *Department of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Elmira Aboutalebi Vand Beilankouhi *Department of Biology, Faculty of Basic Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
Ashkan Kalantary-CharvadehDepartment of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Masoud HamzaviDepartment of Food Science and Technology, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bashir MosayyebiDepartment of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran.
Hassan SedghiDepartment of Toxicology, Faculty of Pharmacy, Islamic Azad University, Branch, Ahar, Iran.
Amir Ghorbani HaghjoDepartment of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Saeed Nazari Soltan AhmadDepartment of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Nazari.S@Tbzmed.ac.ir.ORCID http://orcid.org/0000-0002-6831-7624
Tabriz University of Medical Sciences · IRIslamic Azad University of Ahar · IRIslamic Azad University of Tabriz · IRNational Nutrition and Food Technology Research Institute · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-small cell lung cancer is the most common type of lung cancer, accounting for more than 80% of this tumor. Ubiquitin-specific protease (USP) 14 is one of the 100 deubiquitinating enzymes that is overexpressed in lung cancer and has been validated as a therapeutic target. The aim of this study is to determine whether the accumulation of ubiquitinated proteins results in endoplasmic reticulum (ER) stress-mediated autophagy. To inhibit USP-14, A549 lung cancer cells were treated with USP-14 siRNA and IU1-47 (20 μM). The protein level, mRNA expression, and cell cycle analysis were evaluated using Western blot, real-time PCR, and flow cytometry, respectively. We found that treating A549 cells with USP14 inhibitors significantly reduced the proliferation rate and induced cell cycle arrest at G2/M phase. We also found that USP14 inhibitors did not induce apoptosis but actually induced autophagy through accumulation of ubiquitinated proteins/ER stress/unfolded protein response (UPR) axis. Moreover, we have for the first time demonstrated that the USP14 inhibition induces ER stress-mediated autophagy in A549 cells by activation of c-Jun N-terminal kinase 1 (JNK1). In conclusion, the current investigation represents a new mechanism by which inhibition of USP14 triggers autophagy via ER stress-mediated UPR in A549 cells.

Indexed as

ApoptosisAutophagyEndoplasmic Reticulum StressA549 CellsBiomarkers, TumorCell Cycle CheckpointsCell ProliferationCell SurvivalHumansLung NeoplasmsUbiquitinated ProteinsUbiquitin ThiolesteraseBiomarkers, TumorUbiquitinated ProteinsUbiquitin ThiolesteraseUSP14 protein, humanAutophagyEndoplasmic reticulum stressJNKNSCLCUbiquitin-proteasome

Identifiers

PMID32632734
PMCPMC7591669
OpenAlexW3038750969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.